Literature DB >> 20053376

The epigenetics of social adversity in early life: implications for mental health outcomes.

Patrick O McGowan1, Moshe Szyf.   

Abstract

An organism's behavioral and physiological and social milieu influence and are influenced by the epigenome, which is composed predominantly of chromatin and the covalent modification of DNA by methylation. Epigenetic patterns are sculpted during development to shape the diversity of gene expression programs in the organism. In contrast to the genetic sequence, which is determined by inheritance and is virtually identical in all tissues, the epigenetic pattern varies from cell type to cell type and is potentially dynamic throughout life. It is postulated here that different environmental exposures, including early parental care, could impact epigenetic patterns, with important implications for mental health in humans. Because epigenetic programming defines the state of expression of genes, epigenetic differences could have the same consequences as genetic polymorphisms. Yet in contrast to genetic sequence differences, epigenetic alterations are potentially reversible. This review will discuss basic epigenetic mechanisms and how epigenetic processes early in life might play a role in defining inter-individual trajectories of human behavior. In this regard, we will examine evidence for the possibility that epigenetic mechanisms can contribute to later-onset neurological dysfunction and disease. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20053376     DOI: 10.1016/j.nbd.2009.12.026

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  88 in total

1.  Individual variation and longitudinal pattern of genome-wide DNA methylation from birth to the first two years of life.

Authors:  Deli Wang; Xin Liu; Ying Zhou; Hehuang Xie; Xiumei Hong; Hui-Ju Tsai; Guoying Wang; Rong Liu; Xiaobin Wang
Journal:  Epigenetics       Date:  2012-06-01       Impact factor: 4.528

Review 2.  Neurochemistry of stress. An overview.

Authors:  Nicole Baumann; Jean-Claude Turpin
Journal:  Neurochem Res       Date:  2010-10-27       Impact factor: 3.996

3.  Epigenetics in mental illness: hope or hype?

Authors:  Paul R Albert
Journal:  J Psychiatry Neurosci       Date:  2010-11       Impact factor: 6.186

4.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

Review 5.  DNA methylation correlates of PTSD: Recent findings and technical challenges.

Authors:  Filomene G Morrison; Mark W Miller; Mark W Logue; Michele Assef; Erika J Wolf
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-11-30       Impact factor: 5.067

Review 6.  The embodiment of adverse childhood experiences and cancer development: potential biological mechanisms and pathways across the life course.

Authors:  Michelle Kelly-Irving; Laurence Mabile; Pascale Grosclaude; Thierry Lang; Cyrille Delpierre
Journal:  Int J Public Health       Date:  2012-05-16       Impact factor: 3.380

Review 7.  Nuclear reprogramming and its role in vascular smooth muscle cells.

Authors:  Silvio Zaina; Maria del Pilar Valencia-Morales; Fabiola E Tristán-Flores; Gertrud Lund
Journal:  Curr Atheroscler Rep       Date:  2013-09       Impact factor: 5.113

Review 8.  The biological effects of childhood trauma.

Authors:  Michael D De Bellis; Abigail Zisk
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2014-02-16

9.  Interactive effects of corticotropin releasing hormone receptor 1, serotonin transporter linked polymorphic region, and child maltreatment on diurnal cortisol regulation and internalizing symptomatology.

Authors:  Dante Cicchetti; Fred A Rogosch; Assaf Oshri
Journal:  Dev Psychopathol       Date:  2011-11

10.  Borderline personality disorder: current drug treatments and future prospects.

Authors:  Bayanne Olabi; Jeremy Hall
Journal:  Ther Adv Chronic Dis       Date:  2010-03       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.